Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2021	Jul. 31, 2020	Jul. 31, 2021	Jul. 31, 2020
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	$ (856,845)	$ (764,019)	$ (835,587)	$ (743,420)
Net loss	(21,071)	(20,628)	(42,329)	(41,227)
Ending balance	$ (877,916)	$ (784,647)	$ (877,916)	$ (784,647)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,277,429)	(9,184,603)	(9,256,171)	(9,164,004)
Net loss	(21,071)	(20,628)	(42,329)	(41,227)
Ending balance	$ (9,298,500)	$ (9,205,231)	$ (9,298,500)	$ (9,205,231)